Pathfast POCT: Evaluation presepsin as a key biomarker in sepsis

Antonino Sammartano; Daniele  Malavolta; Giulia  Testa; Roberto  Fiornini; Giovanni  Tortorella; Luigi  Ippolito

doi:10.23750/abm.v95i5.15946

Pathfast POCT: Evaluation presepsin as a key biomarker in sepsis

Authors

Antonino Sammartano U.O. Clinical Pathology, Medical and Diagnostics Department P.O. Fidenza https://orcid.org/0000-0002-1709-4758
Daniele Malavolta Emergency Department, Vaio Hospital, Azienda AUSL of Parma, 43125 Parma, Italy Italy
Giulia Testa U.O. Clinical Pathology, Medical and Diagnostics Department P.O. Fidenza, Azienda AUSL of Parma, 43125 Parma, Italy
Roberto Fiornini Emergency Department, Vaio Hospital, Azienda AUSL of Parma, 43125 Parma, Italy Italy
Giovanni Tortorella Cardiology Unit, Medical and Diagnostics Department P.O. Fidenza, Azienda AUSL of Parma, 43125 Parma, Italy
Luigi Ippolito U.O. Clinical Pathology, Medical and Diagnostics Department P.O. Fidenza, Azienda AUSL of Parma, 43125 Parma, Italy

DOI: https://doi.org/10.23750/abm.v95i5.15946

Keywords:

Presepsin, Point of care testing, Sepsis biomarkers

References

Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41(2):580-637. doi:10.1097/CCM.0b013e31827e83af

Wacker C, Prkno A, Brunkhorst FM, Schlattmann P. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis. 2013;13(5):426-435. doi:10.1016/S1473-3099(12)70323-7

Arai T, Kumasaka K, Nagata K, et al. Prediction of blood culture results by measuring procalcitonin levels and other inflammatory biomarkers. Am J Emerg Med. 2014;32(4):330-333. doi:10.1016/j.ajem.2013.12.035

K. Shirakawa, K. Naitou, J. Hirose, T. Takahashi, S. Furusako, Presepsin (sCD14- ST): development and evaluation of one-step ELISA with a new standard that is similar to the form of presepsin in septic patients, Clin. Chem. Lab. Med. 49 (5) (2011) 937–939.

Kyriazopoulou, E., Leventogiannis, K., Tavoulareas, G. et al. Presepsin as a diagnostic and prognostic biomarker of severe bacterial infections and COVID-19. Sci Rep 13, 3814 (2023). https://doi.org/10.1038/s41598-023-30807-5

Okamura Y, Yokoi H. Development of a point-of-care assay system for measurement of presepsin (sCD14-ST). Clin Chim Acta. 2011;412(23-24):2157-2161. doi:10.1016/j.cca.2011.07.024

Downloads

Published

29-10-2024

Issue

Vol. 95 No. 5 (2024)

Section

LETTERS TO THE EDITOR AND CORRESPONDENCE

License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.

How to Cite

Sammartano A, Malavolta D, Testa G, Fiornini R, Tortorella G, Ippolito L. Pathfast POCT: Evaluation presepsin as a key biomarker in sepsis. Acta Biomed. 2024;95(5):e2024081. doi:10.23750/abm.v95i5.15946

Download Citation